Clexane and Type 2 diabetes - a phase IV clinical study of FDA data

Summary:

Type 2 diabetes is reported as a side effect among people who take Clexane (enoxaparin sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Votrient, and have Metastatic renal cell carcinoma.

The phase IV clinical study analyzes which people have Type 2 diabetes when taking Clexane. It is created by eHealthMe based on reports of 14,633 people who have side effects when taking Clexane from the FDA, and is updated regularly.

What is Clexane?

Clexane has active ingredients of enoxaparin sodium. eHealthMe is studying from 14,679 Clexane users. Check the latest studies of Clexane.

What is Type 2 diabetes?

Type 2 diabetes is found to be associated with 1,432 drugs and 2,345 conditions by eHealthMe. Check the latest studies of Type 2 diabetes.

On Jul, 11, 2026

14,633 people reported to have side effects when taking Clexane.
Among them, 20 people (0.14%) have Type 2 diabetes.

Among these 20 people:

How long have people been on Clexane when they have Type 2 diabetes? *

What is the gender of people who have Type 2 diabetes when taking Clexane? *

female: 50 %
male: 50 %

What is the age of people who have Type 2 diabetes when taking Clexane? *

What are other drugs people take besides Clexane? *

What are other side effects people have besides Type 2 diabetes? *

Gamma-Glutamyltransferase Increased: 10 people, 50.00%
Pneumonia: 7 people, 35.00%
Blood Alkaline Phosphatase Increased: 7 people, 35.00%
Dyspnea (difficult or laboured breathing): 6 people, 30.00%
White Blood Cell Count Decreased: 5 people, 25.00%
Lipoma (a growth of fatty tissue that slowly develops just under your skin): 5 people, 25.00%
Itching: 5 people, 25.00%
Pleural Effusion (water on the lungs): 5 people, 25.00%
Hypercreatininaemia (high levels of creatine in the blood): 5 people, 25.00%
Muscle Strain (an injury to a muscle in which the muscle fibres tear): 5 people, 25.00%

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 25.00%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 5 people, 25.00%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 20.00%
Fatigue (feeling of tiredness): 4 people, 20.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 20.00%
Hypercreatininaemia (high levels of creatine in the blood): 3 people, 15.00%
Venous Thrombosis Limb (blood clot that forms in a vein in the limb): 1 person, 5.00%
Heart Disease: 1 person, 5.00%
Dyspnea (difficult or laboured breathing): 1 person, 5.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Clexane and have Type 2 diabetes?

- Check whether Type 2 diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clexane:

Clexane (14,679 reports)

Type 2 diabetes treatments and more:

Type 2 diabetes (391,582 reports)

Browse all side effects of Clexane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Type 2 diabetes:

Type 2 diabetes (1,432 drugs)

Browse all the conditions that are associated with Type 2 diabetes:

Type 2 diabetes (2,345 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium (the active ingredients of Clexane) and Clexane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.